Patent 7960146 was granted and assigned to Danisco US Inc. on June, 2011 by the United States Patent and Trademark Office.
The present invention provides a novel β-glucosidase nucleic acid sequence, designated bgl3, and the corresponding BGL3 amino acid sequence. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding BGL3, recombinant BGL3 proteins and methods for producing the same.